Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity

被引：29
|
作者：
Camps, Jordi [1 ]
Marsillach, Judit [1 ]
Joven, Jorge [1 ]
机构：
[1] Univ Rovira & Virgili, Hosp Univ St Joan, Inst Invest Sanitaria Pere Virgili, Ctr Recerca Biomed, Reus 43201, Catalunya, Spain
来源：
MINI-REVIEWS IN MEDICINAL CHEMISTRY | 2009年 / 9卷 / 08期
关键词：
Apolipoprotein A-I; fibrates; high-density lipoproteins; lipid peroxidation; nutrition; paraoxonase-1; rosiglitazone; statins; HIGH-DENSITY-LIPOPROTEIN; REDUCES OXIDATIVE STRESS; POMEGRANATE JUICE CONSUMPTION; HORMONE-REPLACEMENT THERAPY; CHOLESTERYL ESTER TRANSFER; E-DEFICIENT MICE; CARDIOVASCULAR-DISEASE; A-I; POSTPRANDIAL PARAOXONASE-1; PESTICIDE SENSITIVITY;
D O I：
10.2174/138955709788681591
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Paraoxonase-1 is a lactonase and an esterase and it plays a protective role in toxicity as well as in diseases involving oxidative stress. Recently, insights into how it may be modulated by environmental factors have acquired clinical relevance. This article reviews the state-of-the-art evidence regarding PON1 modulation by pharmacological products as well as nutritional and lifestyle factors.
引用
收藏
页码：911 / 920
页数：10
相关论文
共 50 条
  • [31] Paraoxonase-1 promoter polymorphism C-107T and serum apolipoprotein AI interact to modulate serum paraoxonase-1 status
    James, RW
    Kalix, B
    Bioletto, S
    Brulhart-Meynet, MC
    PHARMACOGENETICS AND GENOMICS, 2005, 15 (06): : 441 - 446
  • [32] Lower Serum Paraoxonase-1 Activity Is Related to Higher Serum Amyloid A Levels in Metabolic Syndrome
    Kappelle, Paul Jan Willem Herman
    Bijzet, Johan
    Hazenberg, Bouke Pier
    Dullaart, Robin Pieter Frank
    ARCHIVES OF MEDICAL RESEARCH, 2011, 42 (03) : 219 - 225
  • [33] PARAOXONASE-1 ACTIVITY IN SURGICAL PATIENTS WITH SEPSIS
    Bojic, S.
    Simic-Ogrizovic, S.
    Ivanisevic, J.
    Pavlovic, D.
    Sibalic, N.
    Kotur-Stevuljevic, J.
    INTENSIVE CARE MEDICINE, 2011, 37 : S141 - S141
  • [34] Paraoxonase-1 activity in patients with hyperemesis gravidarum
    Verit, Fatma Ferda
    Erel, Ozcan
    Celik, Hakim
    REDOX REPORT, 2008, 13 (03) : 134 - 138
  • [35] ASSESSMENT OF PARAOXONASE-1 ACTIVITY IN DIABETES MELLITUS
    Mathivanan, Ramadevi
    Natarajan, Sasivathanam
    Subramaniyam, Senthilkumari
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (86): : 6420 - 6424
  • [36] Regulation of serum paraoxonase activity by genetic, nutritional, and lifestyle factors in the general population
    Ferré, N
    Camps, J
    Fernández-Ballart, J
    Arija, V
    Murphy, MM
    Ceruelo, S
    Biarnés, E
    Vilelle, E
    Tous, M
    Joven, J
    CLINICAL CHEMISTRY, 2003, 49 (09) : 1491 - 1497
  • [37] Antiepileptic drugs: Impacts on human serum paraoxonase-1
    Beydemir, Sukru
    Demir, Yeliz
    JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2017, 31 (06)
  • [38] The positive relationship of serum paraoxonase-1 activity with apolipoprotein E is abrogated in metabolic syndrome
    Dullaart, Robin P. F.
    Kwakernaak, Arjan J.
    Dallinga-Thie, Geesje M.
    ATHEROSCLEROSIS, 2013, 230 (01) : 6 - 11
  • [39] The Influence of Hemodialysis Membrane Permeability on Serum Paraoxonase-1 Activity and Oxidative Status Parameters
    Horoz, Mehmet
    Kiykim, Ahmet A.
    Cimen, Burak
    Erdem, Abdullah
    ARTIFICIAL ORGANS, 2011, 35 (10) : 923 - 929
  • [40] The Contribution of High Density Lipoprotein Apolipoproteins and Derivatives to Serum Paraoxonase-1 Activity and Function
    James, Richard W.
    Deakin, Sara P.
    PARAOXONASES IN INFLAMMATION, INFECTION, AND TOXICOLOGY, 2010, 660 : 173 - 181
12345